Burkitt's lymphoma is a rare and aggressive blood cancer characterized by a translocation of the MYC gene. It occurs most ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

In this MedPage Today video, Taylor Brooks, MD, of the Cleveland Clinic Cancer Institute, discusses real-world survival ...

Dr Kami Maddocks reflects on fresh data, such as the new epcoritamab combo approval, evolving CD19 sequencing data, and ...

Students at the University of Nebraska-Lincoln have created a pilot program for the Lymphoma Research Foundation they hope ...

The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal ...

Trial data on epcoritamab plus rituximab-lenalidomide, a novel CELMoD agent, late-line CAR-T cell therapy, and selecting ...

BOSTON -- Researchers at the National Institutes of Health found a new treatment for lymphoma that is not chemotherapy. The recent study focused on a non-chemotherapy treatment for people with ...

Medically reviewed by Archana Sharma, DO Key Takeaways Leukemia starts in the bone marrow and spreads through the ...

Fred Hutch researchers pioneered bone marrow transplantation, one of the most significant advances in treating lymphoma, leukemia and other blood cancers. We continue to improve bone marrow and blood ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

Researchers at the Johns Hopkins Kimmel Cancer Center’s Ludwig Center developed a new treatment that selectively targets ...